Vycor Medical, Inc. earnings releases VYCO

Vycor Medical, Inc. last reported quarterly results on Aug 14, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $418,264 (-15.7% year over year) and diluted EPS of $0.00. It usually reports 39–45 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 13, 2026.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 39–45 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Aug 14, 2026
45 days after quarter end
Q2 FY2026
ended Jun 30, 2026
0
-15.7%
-0
-193.3%
0.00
May 15, 2026
45 days after quarter end
Q1 FY2026
ended Mar 31, 2026
0
+5.1%
0
+152.1%
0.00
+100.0%
Nov 14, 2025
45 days after quarter end
Q3 FY2025
ended Sep 30, 2025
1
+31.5%
0
+108.3%
0.00
+100.0%
Aug 8, 2025
39 days after quarter end
Q2 FY2025
ended Jun 30, 2025
0
+22.2%
0
+338.0%
0.00
Apr 15, 2025
15 days after quarter end
Q1 FY2025
ended Mar 31, 2025
0
+29.5%
-0
-26.0%
-0.01
+0.0%
Nov 13, 2017
44 days after quarter end
—
ended Sep 30, 2017
—
—
—
Aug 11, 2017
42 days after quarter end
—
ended Jun 30, 2017
—
—
—
May 11, 2017
41 days after quarter end
—
ended Mar 31, 2017
—
—
—

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
VYCO (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Boca Raton,, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1424768

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.